Literature DB >> 29149441

Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression.

John F Dickerson1, David H Feeny2,3, Gregory N Clarke4, Alex L MacMillan5, Frances L Lynch4.   

Abstract

PURPOSE: To examine the longitudinal construct validity in the assessment of changes in depressive symptoms of widely used utility and generic HRQL instruments in teens.
METHODS: 392 teens enrolled in the study and completed HRQL and diagnostic measures as part of the baseline interview. HRQL measures included EuroQol (EQ-5D-3L), Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3), Quality of Well-Being Scale (QWB), Pediatric Quality of Life Inventory (PEDS-QL), RAND-36 (SF-6D), and Quality of Life in Depression Scale (QLDS). Youth completed follow-up interviews 12 weeks after baseline. Sixteen youth (4.1%) were lost to follow-up. We examined correlations between changes in HRQL instruments and the Children's Depression Rating Scale-Revised (CDRS-R) and assessed clinically meaningful change in multi-attribute utility HRQL measures using mean change (MC) and standardized response mean (SRM) among youth showing at least moderate (20%) improvement in depression symptomology.
RESULTS: Spearman's correlation coefficients demonstrated moderate correlation between changes in CDRS-R and the HUI2 (r = 0.38), HUI3 (r = 0.42), EQ-5D-3L (r = 0.36), SF-6D (r = 0.39), and PEDS-QL (r = 0.39) and strong correlation between changes in CDRS-R and QWB (r = 0.52) and QLDS (r = - 0.71). Effect size results are also reported. Among multi-attribute utility measures, all showed clinically meaningful improvements in the sample of youth with depression improvement (HUI2, MC = 0.20, SRM = 0.97; HUI3, MC = 0.32, SRM = 1.17; EQ-5D-3L, MC = 0.08, SRM = 0.51; QWB, MC = 0.11, SRM = 0.86; and SF-6D, MC = 0.12, SRM = 1.02).
CONCLUSIONS: Findings support the longitudinal construct validity of included HRQL instruments for the assessment of change in depression outcomes in teens. Results of this study can help inform researchers about viable instruments to include in economic evaluations for this population.

Entities:  

Keywords:  Depression; Health-related quality of life; Longitudinal construct validity; Teens

Mesh:

Year:  2017        PMID: 29149441     DOI: 10.1007/s11136-017-1728-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  43 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication.

Authors:  Gregory Clarke; Lynn Debar; Frances Lynch; James Powell; John Gale; Elizabeth O'Connor; Evette Ludman; Terry Bush; Elizabeth H B Lin; Michael Von Korff; Stephanie Hertert
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-09       Impact factor: 8.829

3.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

4.  Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey.

Authors:  P Grootendorst; D Feeny; W Furlong
Journal:  Med Care       Date:  2000-03       Impact factor: 2.983

Review 5.  Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications.

Authors:  Mirella De Civita; Dean Regier; Abul H Alamgir; Aslam H Anis; Mark J Fitzgerald; Carlo A Marra
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients.

Authors:  Jeffrey M Pyne; William J Sieber; Kristin David; Robert M Kaplan; Mark Hyman Rapaport; D Keith Williams
Journal:  J Affect Disord       Date:  2003-09       Impact factor: 4.839

7.  The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.

Authors:  Oliver H Günther; Christiane Roick; Matthias C Angermeyer; Hans-Helmut König
Journal:  J Affect Disord       Date:  2007-05-29       Impact factor: 4.839

8.  Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

Authors:  David Brent; Graham Emslie; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Marty Keller; Benedetto Vitiello; Louise Ritz; Satish Iyengar; Kaleab Abebe; Boris Birmaher; Neal Ryan; Betsy Kennard; Carroll Hughes; Lynn DeBar; James McCracken; Michael Strober; Robert Suddath; Anthony Spirito; Henrietta Leonard; Nadine Melhem; Giovanna Porta; Matthew Onorato; Jamie Zelazny
Journal:  JAMA       Date:  2008-02-27       Impact factor: 56.272

9.  The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression.

Authors:  Sarah Byford
Journal:  J Ment Health       Date:  2013-04

10.  Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder.

Authors:  Christophe Sapin; Bruno Fantino; Marie-Laure Nowicki; Paul Kind
Journal:  Health Qual Life Outcomes       Date:  2004-05-05       Impact factor: 3.186

View more
  4 in total

1.  Once Bitten Twice Shy: Thinking Carefully Before Adopting the EQ-5D-5L.

Authors:  Jeff Round
Journal:  Pharmacoeconomics       Date:  2018-06       Impact factor: 4.981

2.  Assessing hospitalized patients' quality of life from external indices: the perspectives of lay people and health professionals.

Authors:  Maria Teresa Muñoz Sastre; Sylvie Castanié; Paul Clay Sorum; Etienne Mullet
Journal:  Qual Life Res       Date:  2021-05-06       Impact factor: 4.147

3.  Improvement in Health-Related Quality of Life After Community Acquired Pediatric Septic Shock.

Authors:  Neethi P Pinto; Robert A Berg; Athena F Zuppa; Christopher J Newth; Murray M Pollack; Kathleen L Meert; Mark W Hall; Michael Quasney; Anil Sapru; Joseph A Carcillo; Patrick S McQuillen; Peter M Mourani; Ranjit S Chima; Richard Holubkov; Vinay M Nadkarni; Ron W Reeder; Jerry J Zimmerman
Journal:  Front Pediatr       Date:  2021-08-18       Impact factor: 3.569

4.  The longitudinal validity of proxy-reported CHU9D.

Authors:  Rasmus Trap Wolf; Julie Ratcliffe; Gang Chen; Pia Jeppesen
Journal:  Qual Life Res       Date:  2021-02-13       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.